Dr. Laura Frances Gingras, MD

Dr. Gingras practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Gingras' NPI, 1982903118, was assigned on March 28, 2011. Dr. Gingras graduated from Emory School of Medicine in 2011. Dr. Gingras holds New York license 274740.

Dr. Gingras' primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Gingras' primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. Dr. Gingras is also affiliated with Hospital for Special Surgery. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Gingras to 2 more clinical labs and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gingras practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Gingras' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Gingras is board certified in internal medicine by the American Board of Internal Medicine. Dr. Gingras is licensed in New York.

Dmand AI lists acid reflux, acute skin infection, asthma, atrial fibrillation and flutter, chronic anemia, chronic diabetes, chronic hypertension and chronic kidney disease among the conditions Dr. Gingras treats.

CMS data shows 290 Medicare services from Dr. Gingras across 5 procedure codes in 2024, for 115 Medicare patients. Medicare paid $19,299 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 115 Medicare patients who saw Dr. Gingras in 2024. The largest group is 75 to 84, with 49 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gingras' median patient age at 68, with 68% women.

In 2024, Dr. Gingras wrote 1,180 Medicare Part D claims for 182 patients. 80% of them were for generic drugs. CMS names the drug for 812 of them, across 28 drugs with 11 or more claims each, at $111,310 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Gingras for performance year 2024, reported through an alternative payment model (APM). Dr. Gingras accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gingras as offering telehealth.

Dmand AI links 4 papers to Dr. Gingras in 2021. Dr. Gingras has published most often in Qual Manag Health Care. Dr. Gingras' most frequent co-authors are Rebecca Craig-Schapiro, MD, PhD, Darshana M. Dadhania, MD and Michael C. Gao, MD.

CMS Open Payments shows 1 general payment to Dr. Gingras from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $71.

Dr. Gingras graduated from Emory School of Medicine in 2011.

Dr. Gingras is in network with 7 carriers, including Elevance, Aetna and United Healthcare. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.